Citations

Showing 10 of 108083 citations.

Hemodynamics of Fontan Failure
Egbe, Alexander C. , Connolly, Heidi M. , Miranda, William R. , Ammash, Naser M., Hagler, Donald J. , Veldtman, Gruschen , Borlaug, Barry A. , Veldtman, Gruschen R, Borlaug, Barry A

Mayo Clinic

Circulation: Heart Failure | December 16, 2017 | Volume: 10 | Issue: 12 | Pages: No page available

10.1161/circheartfailure.117.004515 | PMID 29246897 Get It

Background Nonpulsatile pulmonary blood flow in Fontan circulation results in pulmonary vascular disease, but the potential relationships between pulmonary vascular resistance index (PVRI) and Fontan failure have not been studied. The objective was to determine whether the absence of subpulmonary ventricle in the Fontan circulation would make patients more vulnerable to even low-level elevations in PVRI, and when coupled with low cardiac index, this would identify patients at increased risk of Fontan failure. Methods and Results Two hundred sixty-one adult Fontan patients underwent cardiac catheterization; age 26±3 years, men 146 (56%), atriopulmonary Fontan 144 (55%). Patients were divided into 2 groups: those with high PVRI (>2 WU·m 2 ) and low cardiac index <2.5 L min −1 m −2 (group 1, n=70, 30%), and those with normal PVRI and normal cardiac index (group 2, n=182, 70%). Fontan failure was defined by the composite of all-cause mortality, listing for heart transplantation, or initiation of palliative care. There were 68 (26%) cases of Fontan failure during a mean follow-up of 8.6±2.4 years. When compared with group 2, freedom from Fontan failure was significantly lower in group 1: 66% versus 89% at 5 years. The combination of high PVRI and low cardiac index was an independent risk factor for Fontan failure (hazard ratio, 1.84; 95% confidence interval, 1.09–2.85). Conclusions When coupled with low cardiac index, even mild elevations in PVRI identify patients at high risk of Fontan failure. This suggests that pulmonary vascular disease is a key mechanism underlying Fontan failure and supports further studies to understand the pathophysiology and target treatments to pulmonary vascular tone in this population.
Reinventing Radiology: Big Data and the Future of Medical Imaging
Morris, Michael , Saboury, Babak , Burkett, Brian J. , Gao, Jackson, Siegel, Eliot L. , Burkett, Brian, Burkett, Brian

Mayo Clinic

Journal of Thoracic Imaging | December 16, 2017 | Volume: 33 | Issue: 1 | Pages: 4-16

10.1097/rti.0000000000000311 | PMID 29252898 Get It

Purpose:Today, data surrounding most of our lives are collected and stored. Data scientists are beginning to explore applications that could harness this information and make sense of it.Materials and Methods:In this review, the topic of Big Data is explored, and applications in modern health care are considered.Results:Big Data is a concept that has evolved from the modern trend of “scientism.” One of the primary goals of data scientists is to develop ways to discover new knowledge from the vast quantities of increasingly available information.Conclusions:Current and future opportunities and challenges with respect to radiology are provided with emphasis on cardiothoracic imaging.
Dusting versus Basketing during Ureteroscopy–Which Technique is More Efficacious? A Prospective Multicenter Trial from the EDGE Research Consortium
Humphreys, Mitchell R. , Shah, Ojas , Monga, Manoj , Krambeck, Amy E. , Sur, Roger L. , Miller, Nicole L. , Knudsen, Bodo E. , Eisner, Brian H. , Matlaga, Brian R., Chang, Yu‐Hui , Chew, Ben H. , Miller, Nicole L

Mayo Clinic

Journal of Urology | December 15, 2017 | Volume: 199 | Issue: 5 | Pages: 1272-1276

10.1016/j.juro.2017.11.126 | PMID 29253579 Get It

Hybrid-denovo: a de novo OTU-picking pipeline integrating single-end and paired-end 16S sequence tags
Chen, Xianfeng , Johnson, Stephen , Wang, Junwen , Kocher, Jean‐Pierre , Jeraldo, Patricio , Chia, Nicholas , Wang, Junwen , Chia, Nicholas , Chen, Jun

Mayo Clinic

GigaScience | December 15, 2017 | Volume: 7 | Issue: 3 | Pages: No page available

10.1093/gigascience/gix129 | PMID 29267858 Get It

Abstract Background Illumina paired-end sequencing has been increasingly popular for 16S rRNA gene-based microbiota profiling. It provides higher phylogenetic resolution than single-end reads due to a longer read length. However, the reverse read (R2) often has significant low base quality, and a large proportion of R2s will be discarded after quality control, resulting in a mixture of paired-end and single-end reads. A typical 16S analysis pipeline usually processes either paired-end or single-end reads but not a mixture. Thus, the quantification accuracy and statistical power will be reduced due to the loss of a large amount of reads. As a result, rare taxa may not be detectable with the paired-end approach, or low taxonomic resolution will result in a single-end approach. Results To have both the higher phylogenetic resolution provided by paired-end reads and the higher sequence coverage by single-end reads, we propose a novel OTU-picking pipeline, hybrid-denovo, that can process a hybrid of single-end and paired-end reads. Using high-quality paired-end reads as a gold standard, we show that hybrid-denovo achieved the highest correlation with the gold standard and performed better than the approaches based on paired-end or single-end reads in terms of quantifying the microbial diversity and taxonomic abundances. By applying our method to a rheumatoid arthritis (RA) data set, we demonstrated that hybrid-denovo captured more microbial diversity and identified more RA-associated taxa than a paired-end or single-end approach. Conclusions Hybrid-denovo utilizes both paired-end and single-end 16S sequencing reads and is recommended for 16S rRNA gene targeted paired-end sequencing data.
Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses
Zalewski, Nicholas L. , Flanagan, Eoin P. , Keegan, B. Mark

Mayo Clinic

Neurology | December 15, 2017 | Volume: 90 | Issue: 2 | Pages: No page available

10.1212/wnl.0000000000004796 | PMID 29247071 Get It

Intermittent theta-burst transcranial magnetic stimulation for autism spectrum disorder: an open-label pilot study
Abujadi, Caio, Bellini, Bianca B., Brentani, Helena , Marcolin, Marco A., Croarkin, Paul E. , Bellini, Bianca Boura , Marcolin, Marco Antônio

Mayo Clinic

Revista Brasileira de Psiquiatria | December 15, 2017 | Volume: 40 | Issue: 3 | Pages: 309-311

10.1590/1516-4446-2017-2279 | PMID 29236921 Get It

ProbAnnoWeb and ProbAnnoPy: probabilistic annotation and gap-filling of metabolic reconstructions
King, Brendan, Farrah, Terry, Richards, Matthew A., Mundy, Michael , Simeonidis, Evangelos , Price, Nathan D. , Price, Nathan D

Mayo Clinic

Bioinformatics | December 15, 2017 | Volume: 34 | Issue: 9 | Pages: 1594-1596

10.1093/bioinformatics/btx796 | PMID 29267848 Get It

Abstract Summary Gap-filling is a necessary step to produce quality genome-scale metabolic reconstructions capable of flux-balance simulation. Most available gap-filling tools use an organism-agnostic approach, where reactions are selected from a database to fill gaps without consideration of the target organism. Conversely, our likelihood based gap-filling with probabilistic annotations selects candidate reactions based on a likelihood score derived specifically from the target organism’s genome. Here, we present two new implementations of probabilistic annotation and likelihood based gap-filling: a web service called ProbAnnoWeb, and a standalone python package called ProbAnnoPy. Availability and implementation Our tools are available as a web service with no installation needed (ProbAnnoWeb) at probannoweb.systemsbiology.net, and as a local python package implementation (ProbAnnoPy) at github.com/PriceLab/probannopy. Supplementary information Supplementary data are available at Bioinformatics online.
Mitochondrial targeted peptides preserve mitochondrial organization and decrease reversible myocardial changes in early swine metabolic syndrome
Yuan, Fang , Woollard, John R. , Jordan, Kyra L., Lerman, Lilach O. , Eirin, Alfonso , Eirin, Alfonso , Lerman, Amir

Mayo Clinic

Cardiovascular Research | December 15, 2017 | Volume: 114 | Issue: 3 | Pages: 431-442

10.1093/cvr/cvx245 | PMID 29267873 Get It

Intraoperative Immunostaining for Cytokeratin-7 During Mohs Micrographic Surgery Demonstrates Low Local Recurrence Rates in Extramammary Paget's Disease
Damavandy, Ali A., Terushkin, Vitaly , Zitelli, John A. , Brodland, David G., Etzkorn, Jeremy R. , Shin, Thuzar M. , Cappel, Mark A. , Mitkov, Mario , Hendi, Ali , Miller, Christopher J.

Mayo Clinic

Dermatologic Surgery | December 15, 2017 | Volume: 44 | Issue: 3 | Pages: 354-364

10.1097/dss.0000000000001355 | PMID 29517496 Get It

BACKGROUND Extramammary Paget's disease (EMPD) is a rare intraepithelial malignancy with high recurrence rates following standard surgical treatments, ranging from 22% to 60% in large retrospective reviews. OBJECTIVE To evaluate the local recurrence rate of Mohs micrographic surgery (MMS) supplemented with intraoperative immunohistochemistry for cytokeratin-7 (MMS + CK-7) for primary and recurrent EMPD. MATERIALS AND METHODS Retrospective, multi-center, cross-sectional study of patients treated using MMS + CK-7. Demographic, clinicopathologic, treatment, and follow-up data were obtained by chart review. RESULTS The observed local recurrence rate for MMS + CK-7 is 3.3% (2/61 tumors) with a mean follow-up of 43.5 months (1–120 months). Local recurrence occurred in 2.3% (1/43) of primary tumors and 5.6% (1/18) of recurrent tumors. Kaplan–Meier 5-year tumor-free rates are 94.6% overall, 97.1% for primary tumors, and 80.0% for recurrent tumors. The Kaplan–Meier 5-year tumor-free rates for all EMPD tumors treated with MMS + CK-7 versus a historical cohort of MMS alone are 94.6% versus 72.0% (p = .012). CONCLUSION MMS + CK-7 is an effective treatment for EMPD, demonstrating improved outcomes compared with historical controls.
Residual Squamous Cell Carcinoma After Shave Biopsy in Solid Organ Transplant Recipients
Ilyas, Muneeb , Zhang, Nan , Sharma, Amit

Mayo Clinic

Dermatologic Surgery | December 15, 2017 | Volume: 44 | Issue: 3 | Pages: 370-374

10.1097/dss.0000000000001340 | PMID 29517497 Get It

BACKGROUND After histopathological confirmation of a biopsy sample, cutaneous squamous cell carcinoma (cSCC) is often treated surgically; yet, residual tumor within the excision sample is not always found. The prevalence of residual cSCC after shave biopsy in solid organ transplant recipients (SOTRs) is unknown. OBJECTIVE Determine the prevalence of residual cSCC after shave biopsy in SOTRs. METHODS A retrospective case-controlled review was performed from a single center. Data were collected for 117 SOTRs and 117 age-matched nonimmunosuppressed controls diagnosed with shave biopsy–proven cSCC who underwent subsequent wide local excision from January 2004 to December 2016. Multivariable conditional logistic regression was used to determine variables associated with residual tumor in the combined population. Univariate logistic regression was used to investigate if transplant-related variables were associated with residual tumor in the SOTR group. RESULTS Of the 117 SOTRs, 57 (48.7%) had residual tumor within the excisional specimen. Of the 117 controls, 31 (26.5%) had residual tumor within the excisional specimen. Solid organ transplant recipients have 2.59 times greater odds of having residual cSCC after shave biopsy (95% confidence interval: 1.29–5.22, p = .0076). CONCLUSION Solid organ transplant recipients have a higher prevalence of residual cSCC after shave biopsy when compared with nonimmunosuppressed controls and should be prioritized for margin-controlled surgery.